Case 2. Osteonecrosis of the jaws associated with bisphosphonate therapy.
Mignogna
Michele D
MD
Section of Oral Medicine, Dept of Odontostomatological and Maxillofacial Sciences, University Federico II, Naples, Italy.
Fedele
Stefano
S
Lo Russo
Lucio
L
Ciccarelli
Roberto
R
Lo Muzio
Lorenzo
L
D000368:Aged; D050071:Bone Density Conservation Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000150:complications / Q000188:drug therapy / Q000556:secondary; D002292:Carcinoma, Renal Cell / Q000188:drug therapy / Q000556:secondary; D004164:Diphosphonates / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D006931:Hyperbaric Oxygenation; D007093:Imidazoles / Q000009:adverse effects* / Q000627:therapeutic use*; D007568:Jaw / Q000473:pathology*; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000473:pathology; D008297:Male; D010020:Osteonecrosis / Q000139:chemically induced*; D010146:Pain / Q000209:etiology; D000077211:Zoledronic Acid
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid